Measuring HIV Quality of Care - Tabular View

This Tabular View shows the required WHO registration data elements as marked by ^†

Tracking Information

First Received Date ^†

March 14, 2001

Last Updated Date

October 31, 2008

Start Date ^†

Current Primary Outcome Measures ^†

Original Primary Outcome Measures ^†

Change History

Complete list of historical versions of study NCT00012701 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^†

Original Secondary Outcome Measures ^†

Descriptive Information

Brief Title ^†

Measuring HIV Quality of Care

Official Title ^†

Measuring HIV Quality of Care

Brief Summary

The VA is the largest single provider of HIV care in the United States. The late 1990's have seen a revolution in the quality standards for this disease with the onset of Highly Active Antiretroviral Therapy (HAART) and other developments.

Detailed Description

Background:

Objectives:

Our purpose in this project is to develop a method for assessing quality in two important areas of HIV care - antiretroviral medications and opportunistic infection screening and prophylaxis - and explore the determinants of high quality care in order to suggest quality improvement strategies.

Methods:

The analysis has four parts. First, it will describe the level of adherence to the indicators in VA HIV patients nationwide and compare VA HIV patients to national benchmarks. Second, it will analyze facility and patient level predictors of adherence to indicators of quality of care and compare them with the predictors in the non VA population using staged logistic regressions. Third, it will seek to validate certain indicators (e.g. HAART therapy) against clinical outcomes like hospitalization and immune status. We will also model the clinical "price" that the VA pays in suboptimal clinical outcomes as a result of current performance levels. Fourth, we will compare the performance of the facilities after one year of an intensive targeted indicator-specific feedback group versus those receiving aggregate data only.

Status:

Data analysis.

Study Phase

Study Type ^†

Observational

Study Design ^†

Other

Condition ^†

HIV Positive
Facility Level Care
Clinical Reminder

Intervention ^†

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^†

Completed

Enrollment ^†

1600

Completion Date

June 2003

Primary Completion Date

Eligibility Criteria ^†

Inclusion Criteria: Facilities with HIV clinics Exclusion Criteria:

Gender

Both

Ages

Accepts Healthy Volunteers

Contacts ^††

Location Countries ^†

United States

Expanded Access Status

Administrative Information

NCT ID ^†

NCT00012701

Responsible Party

Asch, Steven - Principal Investigator, Department of Veterans Affairs

Secondary IDs ^††

Study Sponsor ^†

Department of Veterans Affairs

Collaborators ^††

Investigators ^†

Principal Investigator:

Steven M. Asch, MD MPH

VA Greater Los Angeles Healthcare System

Information Provided By

Department of Veterans Affairs

Verification Date

July 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.